Agios Pharm Stock Analysis

Agios Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The book value of Agios Pharm was presently reported as 14.5. The company recorded a loss per share of 6.33. Agios Pharm had not issued any dividends in recent years. Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Agios Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 0 people. For more info on Agios Pharm please contact David Schenkein at 617 649 8600 or go to https://www.agios.com.

Agios Pharm Investment Alerts

Agios Pharm Upcoming and Recent Events

Agios Largest EPS Surprises

View All Earnings Estimates

Agios Stock Institutional Investors

Note, although Agios Pharm's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Agios Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agios Pharm's market, we take the total number of its shares issued and multiply it by Agios Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Agios Profitablity

Management Efficiency

Agios Pharm has return on total asset (ROA) of (0.2249) % which means that it has lost $0.2249 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3683) %, meaning that it created substantial loss on money invested by shareholders. Agios Pharm's management efficiency ratios could be used to measure how well Agios Pharm manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of April 2024, Return On Tangible Assets is likely to grow to -0.36. In addition to that, Return On Capital Employed is likely to drop to -0.47. At this time, Agios Pharm's Non Current Assets Total are very stable compared to the past year. As of the 24th of April 2024, Non Currrent Assets Other is likely to grow to about 4.3 M, while Total Assets are likely to drop about 752.6 M.

Technical Drivers

As of the 24th of April, Agios Pharm shows the Downside Deviation of 1.89, risk adjusted performance of 0.1241, and Mean Deviation of 2.16. Agios Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Agios Pharm, which can be compared to its peers. Please confirm Agios Pharm variance, as well as the relationship between the maximum drawdown and semi variance to decide if Agios Pharm is priced correctly, providing market reflects its regular price of 31.81 per share. Given that Agios Pharm has jensen alpha of 0.4101, we suggest you to validate Agios Pharm's prevailing market performance to make sure the company can sustain itself at a future point.

Agios Pharm Price Movement Analysis

Agios Pharm Insider Trading Activities

Agios Pharm Predictive Daily Indicators

Agios Pharm Corporate Filings

Agios Pharm Forecast Models

Agios Pharm's time-series forecasting models are one of many Agios Pharm's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Agios Pharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Agios Pharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Agios shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Agios Pharm. By using and applying Agios Stock analysis, traders can create a robust methodology for identifying Agios entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Agios analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Agios analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Agios Pharm stock analysis indicators help investors evaluate how Agios Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Agios Pharm shares will generate the highest return on investment. By understating and applying Agios Pharm stock analysis, traders can identify Agios Pharm position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

When running Agios Pharm's price analysis, check to measure Agios Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agios Pharm is operating at the current time. Most of Agios Pharm's value examination focuses on studying past and present price action to predict the probability of Agios Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agios Pharm's price. Additionally, you may evaluate how the addition of Agios Pharm to your portfolios can decrease your overall portfolio volatility.

Is Agios Pharm's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.